ÂÜÀòÂÒÂ×

Henry Chen is a seasoned executive and entrepreneur with extensive experience in the biopharma and financial sectors. Currently serving as Chairperson and Chief Executive Officer at Tanvex Biopharma USA, Inc. since December 2023, Henry has previously held leadership roles at the same company, including Chief Executive Officer and Chief Financial Officer. As the Founder and Managing Partner of Delos Capital since 2014, Henry has demonstrated significant expertise in investment management. Prior positions include Chief Executive Officer at Curamir Therapeutics, Inc., and several years at Permira as Partner and Co-head for Asia, along with a tenure as Managing Director at Goldman Sachs and an Associate at Davis Polk & Wardwell LLP. Educational qualifications include a Juris Doctor from Harvard Law School and both a Master of Arts and an AB from Harvard University focused on History and History of Science.